Cudarolimab

Tax included
Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has antitumor activity and can be used in cancer related research.
MedChemExpress 
HY-P99836

Data sheet

Size
Multiple sizes
Reactivity
Orexin Receptor (OX Receptor)
Application
COVID-19-immunoregulation
CAS
2244739-29-3